First Clinical Evaluation of a New Percutaneous Optical Fiber Glucose Sensor for Continuous Glucose Monitoring in Diabetes

Background: This article describes a new fiber-coupled, percutaneous fluorescent continuous glucose monitoring (CGM) system that has shown 14 days of functionality in a human clinical trial. Method: The new optical CGM system (FiberSense) consists of a transdermal polymer optical fiber containing a biochemical glucose sensor and a small fluorescence photometer optically coupled to the fiber. The glucose-sensitive optical fiber was implanted in abdominal and upper-arm subcutaneous tissue of six diabetes patients and remained there for up to 14 days. The performance of the system was monitored during six visits to the study center during the trial. Blood glucose changes were induced by oral carbohydrate intake and insulin injections, and capillary blood glucose samples were obtained from the finger tip. The data were analyzed using linear regression and the consensus error grid analysis. Results: The FiberSense worn at the upper arm exhibited excellent results during 14 wearing days, with an overall mean absolute relative difference (MARD) of 8.3% and 94.6% of the data in zone A of the consensus error grid. At the abdominal application site, FiberSense resulted in a MARD of 11.4 %, with 93.8% of the data in zone A. Conclusions: The FiberSense CGM system provided consistent, reliable measurements of subcutaneous glucose levels in human clinical trial patients with diabetes for up to 14 days.

[1]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[2]  William L Clarke,et al.  Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. , 2005, Diabetes technology & therapeutics.

[3]  J. Schultz,et al.  A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. , 2000, Analytical chemistry.

[4]  Eyal Dassau,et al.  Modular Artificial β-Cell System: A Prototype for Clinical Research , 2008 .

[5]  Ashok Gowda,et al.  Fiber-Coupled Fluorescence Affinity Sensor for 3-Day in Vivo Glucose Sensing , 2007, Journal of diabetes science and technology.

[6]  Darrell M. Wilson,et al.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2010 .

[7]  B H Ginsberg,et al.  A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. , 2000, Diabetes care.

[8]  A. Müller,et al.  Safety and accuracy of a new long‐term subconjunctival glucose sensor , 2012, Journal of diabetes.

[9]  S. Garg,et al.  Continuous Home Monitoring of Glucose , 2007, Diabetes Care.

[10]  R. McNichols,et al.  A Human Pilot Study of the Fluorescence Affinity Sensor for Continuous Glucose Monitoring in Diabetes , 2012, Journal of diabetes science and technology.

[11]  First Clinical Evaluation of a New Long-Term Subconjunctival Glucose Sensor , 2012, Journal of diabetes science and technology.

[12]  Jerome S. Schultz,et al.  Competitive-binding assay method based on fluorescence quenching of ligands held in close proximity by a multivalent receptor , 1997 .

[13]  Preclinical in vivo study of a fluorescence affinity sensor for short-term continuous glucose monitoring in a small and large animal model. , 2008, Diabetes technology & therapeutics.

[14]  Howard Wolpert,et al.  Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2009 .

[15]  Ashok Gowda,et al.  In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring. , 2006, Diabetes technology & therapeutics.

[16]  Sohrab Mansouri,et al.  A Miniature Optical Glucose Sensor Based on Affinity Binding , 1984, Bio/Technology.

[17]  Ronald Brazg,et al.  A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes. , 2003, Diabetes technology & therapeutics.

[18]  J. Brauker,et al.  Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. , 2009, Diabetes technology & therapeutics.

[19]  J. Schultz,et al.  Affinity sensors for individual metabolites. , 1979, Biotechnology and bioengineering symposium.

[20]  D. Klonoff.  Continuous glucose monitoring: roadmap for 21st century diabetes therapy. , 2005, Diabetes care.

[21]  N. Evans,et al.  Fluorescence-based glucose sensors. , 2005, Biosensors & bioelectronics.

[22]  Frank Küster,et al.  Blood Glucose Self-Monitoring with a Long-Term Subconjunctival Glucose Sensor , 2013, Journal of diabetes science and technology.

[23]  David L. Meadows,et al.  Design, manufacture and characterization of an optical fiber glucose affinity sensor based on an homogeneous fluorescence energy transfer assay system , 1993 .

[24]  Howard C. Zisser,et al.  Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements , 2009, Journal of diabetes science and technology.

[25]  G L Coté,et al.  A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. , 1999, Analytical chemistry.

[26]  Benchmark data from the literature for evaluation of new glucose sensing technologies. , 2001, Diabetes technology & therapeutics.

[27]  Allyson Beuhler,et al.  In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring. , 2004, Biosensors & bioelectronics.

[28]  J. Schultz,et al.  Fiber-optic biosensors based on fluorescence energy transfer. , 1988, Talanta.

[29]  Josep Vehí,et al.  Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices , 2010, Sensors.

[30]  J. Mastrototaro,et al.  The MiniMed continuous glucose monitoring system. , 2000, Diabetes technology & therapeutics.

[31]  R. Brazg,et al.  Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System , 2007, Diabetes Care.

[32]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[33]  J. Schultz,et al.  Affinity Sensor: A New Technique for Developing Implantable Sensors for Glucose and Other Metabolites , 1982, Diabetes Care.

[34]  Eyal Dassau,et al.  Modular artificial beta-cell system: a prototype for clinical research. , 2008, Journal of diabetes science and technology.